Skye Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Skye Bioscience, Inc. (SKYE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $126.96 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-05-11
- Skye Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2026-03-31 was $126.96K.
- Skye Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2020 was $18.25K, a 66.67% decline from fiscal 2019.
- Skye Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2019 was $54.76K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|
| 2026-03-31 | $126.96K 10-Q · filed 2026-05-11 | ||
| 2023-12-14 | $5.33K 10-K · filed 2025-03-20 | ||
| 2022-12-15 | $1.33M 10-K · filed 2023-03-31 | ||
| 2022-12-14 | $5.33K 10-K · filed 2024-03-22 | ||
| 2020-12-31 | $18.25K 10-K · filed 2021-03-02 | ||
| 2019-12-31 | $54.76K 10-K · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |